A randomised study comparing intermittent to continuous administration of magnesium aspartate hydrochloride in cisplatin-induced hypomagnesaemia.
Vokes
E E
EE
Department of Medicine, University of Chicago Pritzker School of Medicine, IL.
Mick
R
R
Vogelzang
N J
NJ
Geiser
R
R
Douglas
F
F
D001224:Aspartic Acid / Q000008:administration & dosage* / Q000627:therapeutic use; D002945:Cisplatin / Q000009:adverse effects*; D006258:Head and Neck Neoplasms / Q000188:drug therapy; D006801:Humans; D008274:Magnesium / Q000097:blood*
D001224:Aspartic Acid; D008274:Magnesium; D002945:Cisplatin